# Fresenius Kabi USA, LLC: Azacitidine Injection shortage reverified (unavailable from this maker)

**Score:** 55/100

| Field | Value |
|---|---|
| Manufacturer | Fresenius Kabi USA, LLC |
| Drug | Azacitidine Injection |
| Dosage form | Injection |
| Therapeutic category | Oncology |
| Status | Current |
| Stage | Shortage reverified (still listed) |
| Availability | Unavailable |
| Reason | Discontinuation of the manufacture of the drug |
| Presentations affected | 1 |
| Package NDCs | 63323-771-39 |
| Manufacturer supply note | Discontinuation of the manufacture of the drug |
| First posted | 2020-12-18 |
| Updated | 2026-10-15 |

## Why this score
- Unavailable from this manufacturer.
- Sterile injectable: hospital and 503B demand.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-04T06:10:12.565Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.